High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations

Annals of Clinical Biochemistry

Volumn 45, Issue 2, 2008, Pages 170-176

  Liyanage, Khemanganee E ^a   Hooper, Amanda J ^b   Defesche, Joep C ^c   Burnett, John R ^b,d   Van Bockxmeer, Frank M ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

AMPLICON; APOB GENE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DNA SEQUENCE; EXON; FAMILIAL DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL LIGAND DEFECTIVE APOLIPOPROTEIN B 100 MUTATION; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; NETHERLANDS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION PROCESS; XANTHOMA;

APOLIPOPROTEINS B; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; EXONS; GENETIC SCREENING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; TEMPERATURE;

EID: 44249102978     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2007.007077     Document Type: Article

References (27)

1. Burnett JR, Barrett PHR. Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies. Crit Rev Clin Lab Sci 2002;39:89- 137
2. Innerarity TL, Weisgraber KH, Arnold KS, et al. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci USA 1987;84:6919-23
3. Whitfield AJ, Barrett PHR, van Bockxmeer FM, Burnett JR. Lipid disorders and mutations in the APOB gene. Clin Chem 2004;50:1725-32
4. Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk. Semin Vasc Med 2004;4:259-64
5. Abifadel M, Varret M, Rabes JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003;34:154-6
6. Qian YW, Schmidt RJ, Zhang Y, et al. Secreted PCSK9 downregulates low-density lipoprotein receptor through receptor-mediated endocytosis. J Lipid Res, 2007;48:1488-98
7. Garcia CK, Wilund K, Arca M, et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 2001;292:1394-8
8. Innerarity TL, Mahley RW, Weisgraber KH, et al. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 1990;31:1337-49
9. Boren J, Ekstrom U, Agren B, Nilsson-Ehle P, Innerarity TL. The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. J Biol Chem 2001;276:9214-18
10. Fouchier SW, Kastelein JJ, Defesche JC. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Hum Mutat 2005;26:550-6
11. Gaffney D, Reid JM, Cameron IM, et al. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler Thromb Vasc Biol 1995;15:1025-9
12. Soufi M, Sattler AM, Maerz W, et al. A new but frequent mutation of apoB-100-apoB His3543Tyr. Atherosclerosis 2004;174:11-16
13. Wenham PR, Henderson BG, Penney MD, Ashby JP, Rae PW, Walker SW. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK. Atherosclerosis 1997;129:185-92
14. Fouchier SW, Sankatsing RR, Peter J, et al. High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent. J Med Genet 2005;42:e23
15. Lombardi MP, Redeker EJ, van Gent DH, Smeele KL, Weerdesteijn R, Mannens MM. Molecular genetic testing for familial hypercholesterolemia in The Netherlands: a stepwise screening strategy enhances the mutation detection rate. Genet Test 2006;10:77-84
16. Mamotte CD, van Bockxmeer FM. A robust strategy for screening and confirmation of familial defective apolipoprotein B-100. Clin Chem 1993;39:118-21
17. Motti C, Funke H, Rust S, Dergunov A, Assmann G. Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100. Clin Chem 1991;37:1762-6
18. Kotze MJ, Langenhoven E, Peeters AV, Theart L, Oosthuizen CJ. Detection of two point mutations causing familial defective apolipoprotein B-100 by heteroduplex analysis. Mol Cell Probes 1994;8:513-18
19. Ilmonen M, Helio T, Ebeling T, et al. Screening for mutations in the exon 26 of the apolipoprotein B gene in hypercholesterolemic Finnish families by the single-strand conformation polymorphism method. Hum Mutat 1994;4:217-23
20. Nissen H, Hansen PS, Faergeman O, Horder M. Mutation screening of the codon 3500 region of the apolipoprotein B gene by denaturing gradient-gel electrophoresis. Clin Chem 1995;41:419-23
21. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003;49:853-60
22. World Health Organization. Familial Hypercholesterolaemia: Report of a second WHO Consultation. Geneva: WHO, 1999
23. von Ahsen N, Oellerich M, Schutz E. Limitations of genotyping based on amplicon melting temperature. Clin Chem 2001;47:1331-2
24. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999;41:95-8
25. Aslanidis C, Schmitz G. High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves. Clin Chem 1999;45:1094-7
26. Palais RA, Liew MA, Wittwer CT. Quantitative heteroduplex analysis for single nucleotide polymorphism genotyping. Anal Biochem 2005;346:167-75
27. Herrmann MG, Durtschi JD, Bromley LK, Wittwer CT, Voelkerding KV. Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes. Clin Chem 2006;52:494-503